May 24, 2018 – For Chuck Beams, it was one patient in particular who made him realize just how crucial the 340B program is to uninsured and underinsured patients with serious medical conditions. The patient from Auburn, Ala., required tens of thousands of dollars in infusions and other costly care for his cancer and had no idea how he was going to obtain the treatments until he … [Read more...]
Report: 340B Hospitals Provide Far More Care for Low-Income Patients than Other Hospitals
March 13, 2018—On the eve of an important U.S. Senate hearing on the 340B drug discount program, a new report concludes hospitals in the program treat significantly more low-income patients, provide more uncompensated and unreimbursed care, and are more likely to offer low-income patients the types of critical specialized services that often are not fully … [Read more...]
Does 340B Really Drive Up the Cost Of Cancer Care?
Feb. 8, 2018— Academic experts continue to question claims that the 340B drug discount program is the cause of consolidations of private physician practices and community-based hospitals. They argue the trend toward consolidation is much more complex and due to a series of factors, including changes in reimbursement policies. In the Feb. 8 issue of Forbes magazine, Duke … [Read more...]
Health Policy Experts Question Findings in Controversial NEJM Study
February 2, 2018—A team of independent health policy experts have questioned the major findings in a recent New England Journal of Medicine (NEJM) study critical of the 340B drug pricing program. In its Jan. 24 issue, the journal published a study authored by Sunita Desai, Ph.D., and J. Michael McWilliams, M.D., Ph.D., that raised questions about whether 340B hospitals are … [Read more...]
House Panel Issues 340B Report; 340B Health Both Appreciative and Concerned
January 10, 2018—The full House Energy & Commerce Committee released a report this afternoon calling on Congress to clarify the 340B program’s intent, give the Health Resources and Services Administration (HRSA) more regulatory authority over the program, increase reporting requirements for hospitals, and revise hospital eligibility requirements. 340B Health, which … [Read more...]
Judge Lets CMS Impose Medicare Part B Cuts on 340B Hospitals Starting Jan. 1
December 30, 2017—U.S. District Judge Rudolph Contreras yesterday dismissed on procedural grounds the lawsuit to block a 28.5 percent reduction in 340B hospitals’ Medicare Part B drug reimbursement. The case was dismissed on the basis that hospitals have not yet presented a specific claim for reimbursement that has received the reduced payment rate. The decision left open the … [Read more...]
Judge to Rule by Jan. 1 in 340B Hospital Cuts Lawsuit
December 21, 2017—A federal district judge said today he will rule before the end of the year on whether the Centers for Medicare & Medicaid Services (CMS) can implement a regulation cutting $1.6 billion in Medicare drug reimbursement to 340B disproportionate share hospitals and rural referral centers effective Jan. 1. There “is a lot at stake” in the suit against CMS by … [Read more...]